Bi
Animals
Bismuth
/ chemistry
Catalysis
Cell Death
/ drug effects
Endocytosis
/ drug effects
Female
HeLa Cells
Human Umbilical Vein Endothelial Cells
/ drug effects
Humans
Mice, Inbred BALB C
Mice, Nude
Nanoparticles
/ chemistry
Neoplasms
/ pathology
Povidone
/ chemistry
Radiation-Sensitizing Agents
/ pharmacology
Reactive Oxygen Species
/ metabolism
Semiconductors
Tungsten Compounds
/ chemistry
X-Rays
BiWO
nanomedicine
radiocatalysis
radiosensitization
radiotherapy
Journal
ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991
Informations de publication
Date de publication:
29 May 2019
29 May 2019
Historique:
pubmed:
7
5
2019
medline:
22
11
2019
entrez:
7
5
2019
Statut:
ppublish
Résumé
The radioresistance of tumor cells is considered to be an Achilles' heel of cancer radiotherapy. Thus, an effective and biosafe radiosensitizer is highly desired but hitherto remains a big challenge. With the rapid progress of nanomedicine, multifunctional inorganic nanoradiosensitizers offer a new route to overcome the radioresistance and enhance the efficacy of radiotherapy. Herein, poly(vinylpyrrolidone) (PVP)-modified Bi
Identifiants
pubmed: 31058495
doi: 10.1021/acsami.9b03636
doi:
Substances chimiques
Radiation-Sensitizing Agents
0
Reactive Oxygen Species
0
Tungsten Compounds
0
bismuth wolframate
0
Povidone
FZ989GH94E
Bismuth
U015TT5I8H
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM